RDHL
Redhill Biopharma LtdNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$4.16M
P/E Ratio
0.00
EPS
$0.00
Beta
4.92
52W High
$3.31
52W Low
$0.71
50-Day MA
$0.91
200-Day MA
$1.32
Dividend Yield
—
Profit Margin
-97.50%
Forward P/E
1428.57
PEG Ratio
0.00
About Redhill Biopharma Ltd
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company is headquartered in Tel Aviv, Israel.
Fundamentals
| Revenue (TTM) | $9.55M |
| Gross Profit (TTM) | $6.16M |
| EBITDA | $-8.34M |
| Operating Margin | -107.30% |
| Return on Equity | -1709.00% |
| Return on Assets | -25.30% |
| Revenue/Share (TTM) | $6.18 |
| Book Value | $-2.45 |
| Price-to-Book | 203.21 |
| Price-to-Sales (TTM) | 0.43 |
| EV/Revenue | 0.158 |
| EV/EBITDA | 0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 58.60% |
| Shares Outstanding | $5.11M |
| Float | $14.95B |
| % Insiders | 0.00% |
| % Institutions | 9.80% |
Historical Volatility
HV 10-Day
56.76%
HV 20-Day
67.97%
HV 30-Day
57.21%
HV 60-Day
53.22%
HV Rank
26.2%
Volatility is currently contracting
Data last updated: 4/16/2026